Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Aug 18.
Published in final edited form as: Carbohydr Res. 2014 Jun 14;0:19–28. doi: 10.1016/j.carres.2014.06.003

Functional identification of a galactosyltransferase critical to Bacteroides fragilis Capsular Polysaccharide A biosynthesis

Jerry M Troutman a,b,*, Sunita Sharma c, Katelyn M Erickson a, Christina D Martinez a
PMCID: PMC4119839  NIHMSID: NIHMS611894  PMID: 24997288

Abstract

Capsular Polysaccharide A (CPSA), a polymer of a four-sugar repeating unit that coats the surface of the mammalian symbiont Bacteroides fragilis, has therapeutic potential in animal models of Multiple Sclerosis and other autoinflammatory diseases. Genetic studies have demonstrated that CPSA biosynthesis is dependent primarily on a single gene cluster within the B. fragilis genome. However, the precise functions of the individual glycosyltransferases encoded by this cluster have not been identified. In this report each of these glycosyltransferases (WcfQ, WcfP and WcfN) have been expressed and tested for their function in vitro. Using a reverse phase high performance liquid chromatography (HPLC) assay, WcfQ and WcfP were found to transfer galactose from uridine diphosphate (UDP)-linked galactose (Gal) to N-acetyl-4-amino-6-deoxy-galactosamine (AADGal) linked to a fluorescent mimic of bactoprenyl diphosphate, the native isoprenoid anchor for bacterial polysaccharide biosynthesis. The incorporation of galactose to form a bactoprenyl-linked disaccharide was confirmed by radiolabel incorporation and mass spectrometry (MS) of purified product. Using varying concentrations of UDP-Gal and enzyme, WcfQ was found to be the most effective protein at transferring galactose, and is the most likely candidate for in vivo incorporation of the sugar. WcfQ also cooperated in the presence of three preceding biosynthetic enzymes to form an isoprenoid-linked disaccharide in a single-pot reaction. This work represents a critical step in understanding the biosynthetic pathway responsible for the formation of CPSA, an unusual and potentially therapeutic biopolymer.

Keywords: Glycosyltransferase, polysaccharide, capsule, isoprenoid, exopolysaccharide

1. Introduction

Capsular polysaccharides, polymers of four to six-sugar repeating units, that coat the surface of bacteria, play critical roles in bacterial physiology and ecology.(1-4) Recently the capsule coat, Capsular Polysaccharide A (CPSA), of the Gram-negative anaerobic mammalian symbiont Bacteroides fragilis has been identified as the key molecular-link between the symbiotic roles of the organism to host biology.(5-9) CPSA is absorbed by host antigen presenting cells, and much like a peptide fragment, is presented on the surface of these cells by Major Histocompatibility Complex Class II molecules.(10-12) Presentation of CPSA fragments leads to a series of cellular signaling events that result in naïve T-cell differentiation into Th1 helper cells, which corrects for an innate imbalance between Th1 and Th2 cells. The biological activity of CPSA appears to be due to its zwitterionic structure (Figure 1) and chemically masking the positive charge associated with the molecule abolishes its beneficial effect.(9)

Figure 1.

Figure 1

Proposed biosynthetic route to the bactoprenyl diphosphate-linked repeating unit of Capsular Polysaccharide A.

The assembly of CPSA is thought to occur through a Wzy dependent pathway in which repeat units are assembled one sugar at a time on a C55 bactoprenyl phosphate (BP, 1) anchor embedded in the bacterial inner membrane (Figure 1).(4, 13) Once the repeating unit is assembled on the anchor, it is then flipped to the periplasm and polymerized by a Wzy polymerase, which is a fully membrane embedded protein that is likely specific for the repeat unit structure. Genetic studies have clearly shown that CPSA biosynthesis is dependent primarily on a single gene cluster in the B. fragilis genome.(13) This cluster of genes encodes proteins similar to an initiating hexose-1-phosphate transferase (WcfS), three glycosyltransferases (WcfN, WcfP, WcfQ), an aminotransferase (WcfR), a galactopyranose mutase (WcfM), a pyruvaltransferase (WcfO) and a repeating unit polymerase (Wzy), among other proteins. The first sugar appended to BP 1 is N-acetyl-4-amino-6-deoxylgalactopyranose (AADGal) in a reaction catalyzed by the membrane-localized protein WcfS, to afford a bactoprenyl diphosphate-linked AADGal (BPP-AADGal 2).(14, 15) Each of the remaining sugars are expected to then be incorporated one at a time by the presumed glycosyltransferases WcfQ, WcfN and WcfP to provide Galf(1→3)-β-GalNAc(1→3)-β-4,6(Pyr)Gal-(1→3)-α-AADGal(1→PP-bactoprenyl 3.(16) The Wzy polymerase then is expected to link the tetrasaccharide repeat unit from the AADGal to the GalNAc residue as many as 120 times to give the capsular polymer. Which glycosyltransferase is responsible for each step cannot be readily predicted based on sequence similarity to known proteins.

Identification of the glycosyltransferase roles in capsular polysaccharide biosynthesis is confounded by the relative simplicity of the polymer itself. Because capsules are made up of repeating units of the same 4-6 sugars, classic microbiological techniques such as gene deletions to determine the role of specific glycosyltransferases involved are limited, as knocking out one gene will simply lead to no capsule expression, without any indication of what sugar is not transferred to the repeating unit.(17) Biochemical characterizations of the pathways responsible for capsule production are often required. The role of the initiating hexose-1-phosphate transferase, WcfS, in CPSA repeat unit biosynthesis was biochemically elucidated utilizing isoprenoid analogues that enhanced the ability to track the production of bactoprenyl phosphate-linked reaction products (Figure 2).(14) These analogues were derived from a chemically synthesized 4-nitroaniline or 2-amideaniline geranyl diphosphate (2AA-GPP 4a, NAGPP 4b) that was then elongated by the enzyme Undecaprenyl Pyrophosphate Synthase (UPPS) in the presence of isopentenyl diphosphate (IPP, 5).(15, 18) The long chain variable length isoprenoid product (6a-b) of these reactions were then cleaved with a commercially available Alkaline Phosphatase to provide monophosphate substrate for WcfS (2AA-B(n)P, 7a, 4NA-B(n)P, 7b). Each of the isoprenoid analogues were substrates for WcfS and the transfer of AADGal-phosphate was observed in a straight-forward reverse phase HPLC assay.(14, 15)

Figure 2.

Figure 2

Enzymatic synthesis of CPSA repeat unit precursors with optically active isoprenoid precursors.

The major advantage of the isoprenoid analogues was the enhanced ability to uniquely and sensitively detect and isolate isoprenoid-linked sugars utilizing the high extinction coefficient 4-nitroanline (E395=9500 M−1 cm−1 detection limit 20 pmoles) and fluorescent anthranilamide (ex. 350 nm em. 450 nm, detection limit=20 fmoles) replacing the terminal isoprene of the anchor (Figure 2). These alternative substrates bypassed conventional methods to study polysaccharide biosynthesis, which typically requires radiolabeled sugars, extractions to follow incorporation of the sugars into the organic soluble isoprenoid, and thin layer chromatography (TLC) to separate products.(19-21) In addition, the bactoprenyl analogues and ease of separation and detection provide straight-forward methods to combine multiple glycosyltransferases and sugar nucleotide modifying enzymes in single pot reactions to produce and isolate precursors for complex polysaccharide biosynthesis.(14, 15) These one-pot systems could provide a method for rapidly producing any number of complex polysaccharides and precursors for use in arrays or therapeutics. With simple access to optically active bactoprenyl diphosphate-linked AADGal, specific questions about the roles of the glycosyltransferases encoded by the CPSA gene cluster can be asked. In this report the activity of each of the three glycosyltransferases encoded by the CPSA biosynthesis gene cluster are tested to identify the next critical step in the biosynthesis of this remarkable and potentially therapeutic glycopolymer.(7, 22-26)

2. Results

2.1. Cloning of WcfN, WcfP and WcfQ

The second step in the assembly of CPSA was presumed to be linkage of galactose to BPPAADGal 2 (Figure 1). To identify whether any of the CPSA gene cluster encoded glycosyltransferases exhibited this activity in vitro, each cluster-encoded glycosyltransferase gene was amplified by the polymerase chain reaction (PCR) from B. fragilis ATCC 25285 genomic DNA and were incorporated into pET-24a expression vectors. The wcfP and wcfQ genes were incorporated through a BamHI and XhoI restriction site in the vector, which would lead to protein encoding a T7 N-terminal and hexahistidine C-terminal tag. Due to an internal BamHI site in the wcfN gene, it was incorporated through an NheI and XhoI restriction site, which would lead to a protein containing only the hexahistidine tag. Each gene introduced into the vector was expressed in E. coli BL-21 RIL cells. No other expression cell types were attempted.

2.2. CPSA gene cluster proteins modify an isoprenoid-linked monosaccharide

In order to test the activity of WcfQ, WcfP and WcfN, cells overexpressing each were lysed then cleared of intact cells by centrifugation, after which the membrane components that remained in the supernatant were separated by ultracentrifugation. The membrane components were homogenized into Tris-HCl (pH=8.0) buffer. This membrane fraction and supernatant from the WcfN, WcfP and WcfQ expressions were mixed with excess uridine diphosphate galactose (UDP-Gal) and the fluorescent anthranilamide bactoprenyl diphosphate-linked AADGal (2AAB(7)PP-AADGal 8a, Figure 2). Each reaction was then analyzed by HPLC under isocratic conditions with 50% 1-propanol/50% 100 mM ammonium bicarbonate and fluorescence detection to identify any changes in the retention of the fluorescent substrate (Figure 3). Membrane fractions from the WcfQ and WcfP, but not WcfN expressions, altered the HPLC retention of the 2AA-B(7)PP-AADGal 8a from 13.0 min to 11.3 min in the presence of UDPGal. No change was observed from reactions using the supernatants (data not shown). In addition, similar reactions were performed with a 2AA-B(8)PP-AADGal 8a and were analyzed by fluorescence HPLC in 55% propanol/45% 100 mM ammonium bicarbonate (Supporting Figure 1a-b) where the 2AA-B(8)PP-AADGal 8a retention time of 11.7 min was altered to 10.2 min with WcfQ and WcfP but not WcfN membrane fractions. These experiments were repeated with different concentrations of WcfQ, WcfP, and WcfN membrane fractions with similar results. Since there was no activity from the WcfN containing membrane preparations, the activity observed with WcfP and WcfQ must have been from the recombinant overexpressed WcfP and WcfQ. Activity was also observed in reaction mixtures that contained all three membrane fractions (data not shown), as well as cell lysates of WcfP and WcfQ, but not WcfN overexpressing cells (data not shown).

Figure 3. WcfP and WcfQ, but not WcfN alter the HPLC retention time of 2AA-B(7)PPAADGal in the presence of UDP-Gal.

Figure 3

Solutions were prepared with 5 μM 2AA-B(7)PPAADGal, 1% Triton, 10 mM MnCl2, 25 mM bicine (pH=8.3), 840 μM UDP-Gal, and 1 mM DTT, and either 45 μg/mL WcfQ, 125 μg/mL WcfP or 70 μg/mL WcfN total protein membrane fractions. After one hour 10 μL was analyzed by HPLC (isocratic 50% 1-Propanol: 50% 100 mM ammonium bicarbonate, detection ex. 350 nm em. 450 nm). The chromatograms shown are representative of a typical experiment, where 1 indicates the retention of 2AA-B(7)PP-AADGal 8a and 2 indicates the position of the new product.

2.3. WcfP, WcfQ and WcfN localize to membrane fractions

The activity of protein in the membrane fractions was surprising considering that WcfQ was predicted by both the TMHMM(27) and DAS(28) transmembrane domain prediction software to not contain a membrane-spanning region (Supporting figure 2), and these software tools only predicted minor transmembrane regions in WcfP and WcfN. The WcfN, WcfP and WcfQ membrane fractions were analyzed by SDS-PAGE gel electrophoresis and Western Blot to determine if the expected overexpressed proteins were present (Figure 4a). Each membrane fraction did contain overexpressed protein with the expected apparent molecular weight (WcfQ: 32 kDa, WcfP: 44 kDa, and WcfN: 34 kDa) and by Western Blot analysis each over-expressed protein cross-reacted with an anti-histidine antibody specific to the C-terminal hexahistidine purification tag encoded by the expression vector (Figure 4b). In addition, both WcfQ and WcfP contained an N-terminal T7-tag, which was detected by Western Blot using an anti-T7 antibody (Figure 4c). As expected, the WcfN protein was not detected by the anti-T7 antibody due to incorporation of the WcfN encoding gene into pET-24a that lacked the T7-tag encoding region. Together with the activity data, these results suggested that both WcfP and WcfQ were functional membrane-associated proteins, and were not simply mis-folded aggregates associated with the lysed cell membranes. However, it was not clear whether WcfN was prepared in a functional form.

Figure 4. Overexpressed WcfQ, WcfN and WcfP associate with E. coli cell membranes.

Figure 4

A) SDS-PAGE analysis of membrane fractions from BL-21 RIL cells overexpressing each construct 1) Protein marker 2) WcfQ (32 kDa) 3) WcfP (44 kDa) 4) WcfN (34 kDa). Arrows indicate overexpressed protein. B) anti-histidine Western Blot of membrane fractions and detection with anti-rabbit alkaline phosphatase-linked antibody, numbering is the same as A. C) anti-T7 Western Blot of membrane fraction, detection by anti-T7 antibody-linked to alkaline phosphatase, number is the same as in A.

2.4. Confirmation that galactose is transferred to AADGal

A change in HPLC retention time of 2AA-BPP-AADGal 8a strongly suggested glycosyltransferase activity from WcfQ and WcfP preparations. To conclusively demonstrate the incorporation of galactose, WcfQ, WcfN and WcfP containing membrane fractions were mixed with UDP-[3H]Galactose and 2AA-B(8)PP-AADGal 8a. Each reaction was then analyzed by HPLC as described above. [3H]Galactose was incorporated into material that was retained on the HPLC column with WcfQ and WcfP membrane preparations, but not WcfN (Figure 5a-c). Inspection of the fluorescent chromatogram of each reaction indicated that a new fluorescent peak was observed with WcfQ that overlapped with the radiolabeled material, yet a similar fluorescent product peak was not observed with WcfP or as expected with WcfN (Supporting figure 1a). The total radioactivity associated with the WcfP reaction was also an order of magnitude lower than observed with the WcfQ membrane fraction. Detection of radiolabel incorporation would be expected to be more sensitive than fluorescence and since these reactions were prepared with only 10 nM 2AA-B(8)PP-AADGal 8a and 63 nM UDP-[3H]Gal it was possible that the WcfP product was retained to the same extent as the WcfQ product, but the very low turnover was not detectable by fluorescence. To test this possibility, WcfP, WcfQ and WcfN reactions identical to the radiolabel reactions were prepared except with 60 μM UDP-Gal to enhance total turnover. HPLC analysis confirmed that a new fluorescent product was formed with WcfP, but the total turnover was clearly lower than that observed with WcfQ (Supporting figure 1b). A similar radiolabeled experiment was performed with WcfQ and 1 μM 2AAB(7)PP-AADGal 8a with 12 μM UDP-[3H]Gal to ensure that both the 7-Z and 8-Z isoprenoids were substrates for WcfQ and accepted [3H]galactose from UDP-[3H]Gal. As expected, radiolabel was detected in these reactions with a retention time consistent with the fluorescent product (Supporting figure 3a-b). Finally, the fluorescent material from a non-radiolabeled WcfQ reaction with 2AA-B(7)PP-AADGal 8a was purified then analyzed by ESI-MS where a mass near the expected 2AA-B(7)PP-AADGal-Gal mass of 1273.72 amu (actual 1273.86 amu) was observed by positive ion electrospray ionization (ESI)-MS plus one sodium adduct of expected mass 1295.70 amu (actual 1295.97 amu) (Figure 5d).

Figure 5. Confirmation that galactose is incorporated into 2AA-BPP-monosaccharide.

Figure 5

One minute HPLC (isocratic 55% 1-Propanol: 45% 100 mM ammonium bicarbonate) fractions of 2AA-B(8)PP-AADGal 8a reactions with UDP-[3H]Gal in the presence of A) WcfQ, B) WcfP, or C) WcfN. For fluorescence retention time comparison see supporting figure 1. D) Positive ion mode ESI-MS spectrum of purified 2AA-B(7)PP-AADGal-Gal expected MW=1273.72 amu.

2.5. Single-pot biosynthetic activity of WcfQ

The ability for multiple proteins to work in the presence of one another and various substrates in vitro would be advantageous for the production of complex polysaccharides without the need to isolate various intermediates. The monosaccharide-linked product of WcfS can be enzymatically synthesized through a one-pot reaction with the enzyme PglF, a dehydratase from Campylobacter jejuni,(29, 30) WcfR, an aminotransferase from B. fragilis, and WcfS with relevant co-factors and UDP-GlcNAc.(14) To test whether galactose from UDP-Gal with WcfQ could be incorporated in a single pot reaction, a mixture was prepared with each of the enzymes and substrates for 2AA-B(8)PP-AADGal 8a production and was monitored by HPLC until the majority of the 2AA-B(8)P 7a starting material was consumed (Figure 6). UDP-Gal and WcfQ were then added and the reaction was monitored under the same conditions. We found that WcfQ was competent to transfer galactose and the retention time change was consistent with reactions using purified bactoprenyl substrate.

Figure 6. One pot preparation of 2AA-B(8)PP-AADGal-Gal.

Figure 6

2AA-B(8)P (1) was mixed with PgF (C. jejuni), WcfR (B. fragilis) and WcfS (B. fragilis) in the presence of UDP-GlcNAc, NAD+, PLP and Glutamate. The reaction was monitored by HPLC (isocratic 55% 1-Propanol: 45% 100 mM ammonium bicarbonate) until significant WcfS product was formed (2) (lower trace). UDP-Gal and WcfQ membrane fraction was then added and the reaction was monitored for conversion to the disaccharide (3) (upper trace).

2.6. Specificity of the glycosyltransferases

A major advantage to the fluorescent isoprenoid was that specificity studies of the glycosyltransferases could be conducted without requiring access to expensive radiolabeled nucleotide-linked sugars. In addition, reactions could be prepared then left for automated HPLC analysis without requiring extractions or TLC. Each glycosyltransferase-containing membrane fraction was analyzed in an endpoint assay with 2AA-B(7)PP-AADGal 8a and four additional, commercially available nucleotide-linked sugars. UDP-glucose (UDP-Glc), UDP-glucuronic acid (UDP-GlcA), UDP-N-acetylgalactosamine (UDP-GalNAc) nor UDP-GlcNAc were alternative substrates for either WcfP (Supporting Figure 4) or WcfN (data not shown). However, WcfQ could catalyze the addition of glucose to the 2AA-B(7)PP-linked monosaccharide 8a (Supporting Figure 4). The overall turnover with galactose and WcfQ was near quantitative, while under identical assay conditions glucose was only utilized to consume about 60% of the isoprenoid-linked monosaccharide. WcfQ was therefore able to transfer both glucose and galactose to the 2AA-B(7)PP-AADGal 8a, but appeared more effective at transferring galactose. In addition, the overall turnover observed with WcfP was lower than that observed with WcfQ, which was consistent with the radiolabeled sugar substrate turnover described above.

2.7. UDP-Gal is the preferred substrate for WcfQ

The overall product formed in the WcfQ and WcfP reactions appeared to be dependent on the concentration of nucleotide-linked sugar and total protein present in the reaction mixtures. Taking advantage of this influence on product yield, and to optimize that yield, the concentration dependence of UDP-Glc and UDP-Gal on total turnover was used in endpoint assays to determine which substrate was the preferred substrate for WcfQ. WcfQ activity assays were prepared with WcfQ and nucleotide-linked sugars at 62, 310 and 620 μM with 1 μM 2AA-B(8)PP-AADGal 8a. With membrane fractions of WcfQ containing 110 ng of total protein, no detectable glucose product was observed, yet 8.5-22% of the isoprenoid was consumed with UDP-Gal (Figure 7a). However, when protein concentration was increased to 1.1 μg of total protein, isoprenoid was consumed to 13, 33, and 43% in the presence of UDP-Glc at 62, 310 and 620 μM respectively. Under these conditions at 62 μM UDP-Gal, 80% of the isoprenoid was consumed. It is important to note that the total protein concentration was based on a Bradford assay(31) of the membrane fraction and even if all protein was WcfQ the total in the reactions would still be sub-stoichiometric. Overall, this data strongly suggested that the preferred substrate for WcfQ, especially with respect to concentration dependence, was UDP-Gal over UDP-Glc.

Figure 7. Specificity of WcfQ and WcfP containing membrane fractions.

Figure 7

2AA-B(8)PPAADGal and each sugar and enzyme membrane fraction (mf) indicated were mixed then analyzed by HPLC after one hour. Product turnover is based on the percent fluorescence attributed to the product. A) concentration of protein and sugar effects on turnover with WcfQ B) concentration of protein and sugar effects on turnover with WcfP. Each value is the average of duplicate measurements and error bars represent the values of each measurement. Over an hour passed between each duplicate and little difference was observed in product formed.

2.8. WcfQ is the likely biologically active galactosyltransferase

The dependence of sugar and enzyme concentration on total isoprenoid consumed with WcfQ suggested that WcfP turnover may also be affected by these parameters. Reactions with 2AAB(8)PP-AADGal 8a, WcfP and UDP-Gal at 84, 420, and 840 μM were prepared then analyzed by HPLC. Higher concentrations of UDP-Gal did improve overall turnover with 6 μg total protein WcfP (Figure 7b). However, it is also important to note that the volume of membrane fraction added to the reaction was higher than that used with the WcfQ membrane fractions. This is important because as shown in figure 4a-c background protein was higher with WcfP and the total WcfP present was higher between the two preparations. In addition, when the WcfP membrane fraction was diluted and assayed the total turnover with UDP-Gal was significantly lower than observed with WcfQ at half the volume and five-fold less total protein. Taken together these results suggest that WcfQ is the likely transferase responsible for incorporation of galactose into the CPSA repeat unit.

2.9. Optimization of glycosyltransferase total turnover

The endpoint assay described above was next used to maximize total turnover of the glycosyltransferases and determine optimum conditions without kinetic assays. Under conditions where less than 50% turnover was expected to be observed based on the studies above, four buffers, Bicine (pH=8.3), HEPES (pH=7.4), Tris-HCl (pH=8.0) and MOPS (pH=6.5), were tested for optimum turnover with WcfQ and UDP-Gal. Bicine clearly promoted the highest turnover of the 1 μM 2AA-B(8)PP-AADGal 8a starting material where 30% was consumed while less than 10% was consumed with HEPES and no product was observed with Tris-HCl or MOPS (Figure 8a). However, Tris-HCl would allow for product formation with higher concentrations of enzyme (data not shown). Next a set of standard conditions were established where reactions were performed in Bicine, 1% Triton-X-100, 200 mM NaCl, 1 mM DTT, 10 mM MnCl2 and 1% DMSO with 0.5 μM 2AA-B(8)PP-AADGal 8a. When the detergent was changed to 0.1% n-dodecyl-β-D-maltoside very little turnover was observed (data not shown). In addition, with 0.1% triton-X-100 total turnover was similar to 1%, but not as much isoprenoid was solubilized for HPLC analysis (data not shown). When the triton-X-100 concentration was increased to 2% a near two-fold decrease in product was observed with both WcfQ and WcfP (Figure 8b). The concentration of DMSO did not appear to influence product formation as 5 and 10% concentrations had very little if any effect on WcfQ or WcfP reactions. However, DTT increased to 10 mM over 1 mM enhanced turnover by over two-fold with WcfQ and also improved WcfP activity, although the effect did not appear to be as dramatic. Next the influence of salt on the reaction was tested (Figure 8b). Both the WcfQ and WcfP reactions were enhanced with increasing salt concentration. The optimum salt concentration for WcfQ was 200 mM NaCl or KCl and 100-200 mM NaCl with WcfP. KCl was less effective with WcfP.

Figure 8. Optimization of WcfQ and WcfP.

Figure 8

Figure 8

Reactions of UDP-Gal and 2AA-B(8)PP-AADGal 8a in varying conditions as indicated were analyzed by HPLC. A) Effect of varying 25 mM buffers on WcfQ. B) Effect of Triton-X-100, DMSO and DTT on WcfQ and WcfP catalyzed reactions. C) Effect of salt and salt concentration on WcfQ and WcfP. Each value is the average of duplicate measurements and error bars represent the values of each measurement. Over an hour passed between each duplicate analysis. Note that in panel A 1 μM 2AA-B(8)PP-AADGal 8a was used, while in B and C 0.5 μM was used.

2.10. Manganese enhances product turnover by WcfQ and WcfP

Many glycosyltransferases are dependent on divalent metals for catalysis.(3, 20, 32, 33) In the above assays either MgCl2 or MnCl2 was present, yet it was not clear which divalent metal was optimum. WcfQ and WcfP activity with UDP-Gal and 2AA-B(8)PP-AADGal 8a were tested in the presence of MgCl2, MnCl2, CaCl2 or no metal to determine if exogenous divalent metal promoted catalysis and if one was more effective than another. With WcfQ and WcfP, MnCl2 was the most effective allowing for 55% and 100% consumption of isoprenoid with 4.5 μg/mL WcfQ or 62 μg/mL WcfP respectively (Figure 9a). Both MgCl2 and CaCl2 did enhance catalysis over no metal but to the same extent whether WcfQ or WcfP was utilized. Very little if any (<2% with WcfQ and <10% with WcfP) isoprenoid was consumed without any metal present. Since WcfQ appeared to be the most effective enzyme at catalyzing galactose incorporation, the concentration dependence on MnCl2 was also tested. A significant concentration dependent increase in isoprenoid consumed was observed from 0.5-10 mM MnCl2 with the WcfQ preparation (Figure 9b).

Figure 9. Divalent metals ions are required for effective catalysis by WcfQ and WcfP.

Figure 9

Reactions with A) WcfP (white) or WcfQ (gray) in solutions of UDP-Gal and 2AA-B(8)PPAADGal 8a and 10 mM MgCl2, MnCl2, CaCl2 or no metal were analyzed by HPLC and product turnover was determined after one hour. B) WcfQ product turnover with increasing concentrations of MnCl2.All measurements were performed in duplicate.

2.11. Activity of purified WcfQ

It was not clear whether the presence of membrane components was required for effective product formation by the glycosyltransferases. To remove WcfQ, WcfP and WcfN from the membrane, the fractions were homogenized in Triton-X-100 or n-Dodecyl-β-D-maltoside. Following homogenization the proteins were purified by Ni2+ immobilized metal affinity chromatography. We found that after homogenization and analysis of the membrane fractions that little of the protein was removed. However, enough WcfQ was isolated and purified to detect by Western Blot analysis (supporting figure 5). The purified WcfQ was tested with 2AAB(8)PP-AADGal 8a but no function was observed from the protein (data not shown). These results suggested that membrane components were required for function, but it is not possible to rule out that the isolated protein was not in its functional form.

3. Discussion

In this report we have shown that two proteins encoded by the CPSA biosynthesis gene cluster are competent to catalyze addition of galactose to a fluorescent bactoprenyl diphosphate-linked monosaccharide. With respect to overall turnover WcfQ was clearly more effective than WcfP, which suggests that it is the protein more likely to incorporate galactose into the structure in vivo. Importantly, only one hydroxyl is available in AADGal for linkage, so the linkage position is likely appropriate. However, the configuration of that linkage has not been identified in this work. Attempts to characterize the anomeric configuration from WcfQ and WcfP disaccharide products enzymatically with α-galactosidase and β-galactosidase were inconclusive (data not shown). However, based on the Carbohydrate-Active enZYmes (CAZY)(34) database the WcfQ sequence matches the GT2 family of glycosyltransferases which invert the configuration of the anomeric carbon of the donor, while WcfP is similar to a GT4 family glycosyltransferase, which retains the anomeric stereoconfiguration of the donating sugar, which would be α from the UDPGal. The published structure of the CPSA repeating unit suggests that the linkage should be in a β-configuration.(16) This supports our conclusion that WcfQ is the protein responsible for introducing galactose, and that it introduces the sugar in the appropriate β-configuration.

The biological activity of CPSA appears to be heavily dependent on its relatively rare zwitterionic polymeric structure,(35-37) where the positive charge is associated with the amino sugar AADGal, and the negative charge is associated with a pyruvalated galactose residue. Previously our group has shown the incorporation of the positively charged AADGal-phosphate into bactoprenyl phosphate as a precursor to the repeating unit of CPSA.(14) If WcfQ catalyzes incorporation of galactose then it would be expected that either WcfN or WcfP catalyzes the introduction of the subsequent GalNAc residue (Figure 1). However, we did not observe this function from WcfN, WcfP or WcfQ (data not shown) with either the WcfP or WcfQ derived disaccharide. We suspect that the pyruvate moiety on the galactose must first be incorporated before addition of the next sugar residue. The CPSA biosynthesis cluster gene wcfO encodes a putative pyruvaltransferase, and current work is focused on determining whether the disaccharide produced in this study is a substrate for that protein. However, it is also possible, although not likely, that a glycosyltransferase outside the CPSA biosynthesis gene cluster catalyzes GalNAc transfer and pyruvalation is not required. In addition, WcfN may not have been isolated in a functional form and may require re-folding in order to function. It is much less likely that WcfP is inappropriately folded since some function was observed from the protein, suggesting that the protein was not just a mis-folded aggregate. The GalNAc linkage will require a retaining glycosyltransferase since the anomeric configuration in the CPSA structure is alpha. As discussed above, WcfP is related to the GT4 family of proteins suggesting that it is a retaining glycosyltransferase, while WcfN appears to be a member of the GT2 family, which inverts the stereochemistry of the anomeric carbon, and members of this family have also been identified that transfer galactofuranose. It is therefore more likely that WcfP catalyzes GalNAc transfer to the galactose, and since the protein has some function associated with it, it is also likely that the pyruvate must be incorporated before the next residue. Very little is known about the pyruvaltransferases and only a few have been characterized.(38-41) The disaccharide building block produced in this work will be key to determining how the negatively charged pyruvate moiety is introduced, as it is not clear whether the pyruvate is incorporated into the di-, tri- or tetra-saccharide or if it is introduced after repeating unit polymerization.

Surprisingly, WcfQ could also effectively transfer glucose, while GlcA, GlcNAc and GalNAc were not transferred to the prenyl-linked monosaccharide. Based on turnover and the amount of UDP-Glc required, Glc was not as efficiently incorporated, and WcfQ appeared more selective for galactose. Traditionally the analyses of oligosaccharide biosynthetic pathways have depended heavily on radiolabel studies that are expensive to conduct or ESI-MS studies.(3, 20, 32, 33) The relative ease by which these isoprenoid-linked sugars can be screened for activity using the isoprenoid analogue is a major advantage over the use of radiolabeled sugars. Rare sugars that are not readily available in 14C or 3H forms can be screened to test specificity of these enzymes. This provides a method to test stereochemical dependence on enzyme substrate recognition as well as a way to build other complex sugar structures without requiring a different enzyme from another organism. For example, the studies described here show that replacing the galactose 2-position hydroxyl with an N-Acetyl group or oxidation of the C6 position negatively affects the ability of the proteins to transfer a sugar to the AADGal substrate. However, in the case of WcfQ the stereochemistry of the C4 position appears to have very little influence on the ability of the enzyme to recognize substrate. It would be of considerable interest to see what other types of prenyl-linked monosaccharides WcfQ or WcfP can link galactose or glucose to. A more complete collection of isomers would be ideal to further these studies and with the methods described here would not require radiolabeled nucleotide-linked sugar synthesis.

4. Experimental procedures

4.1. General Procedures

All HPLC was performed on an Agilent 1100 HPLC system equipped with diode array and fluorescence detectors. All analysis utilized a flow rate of 1 mL/min with isocratic conditions of 50% 1-propanol 50% 100 mM ammonium bicarbonate for B7 isoprenoids and 55% 1-propanol 45% 100 mM ammonium bicarbonate for B8 isoprenoids, unless noted otherwise. All chromatography was performed on a reverse phase C18 Agilent Eclipse XDB-C18, 5 μm, 4.6 × 150 mm column. ESI-MS was performed on a Thermo MSQ Plus (single quadrupole) equipped ESI in positive ion mode with a 75 V cone voltage and 450 °C capillary temperature. 2AA-B(7-8)PP-AADGal was synthesized as described previously.(14, 15) WcfQ, N and P reactions were left unquenched for more than one hour, unless stated otherwise, before HPLC analysis and at least one hour passed before analysis of duplicate reactions. All reactions were performed at room temperature 22-24 °C. Concentrations of isoprenoid were based on the extinction coefficient of anthranilamide (ε350=2500 M−1 cm−1). Uridine diphosphate-linked sugar concentrations were based on the extinction coefficient of uridine (ε280 =10,000 M−1 cm−1).

4.2. WcfQ, P and N PCR and vector insertion

Polymerase chain reaction amplifications on each gene were performed using B. fragilis genomic DNA (ATCC 25285) and the oligonucleotide primers shown in table 1 of the supporting information. The wcfQ and wcfP were digested with BamHI and XhoI, wcfN was digested with NheI and XhoI. All three genes were subsequently ligated into a pET-24a vector digested with the appropriate restriction enzyme for each gene. Chemically competent E. coli DH5α cells were transformed with each ligated vector and Kanamycin resistant clones were selected. Plasmids were isolated from the Kanamycin resistant clones and sequenced to confirm introduction of each gene (Eurofins-Operon). Chemically competent E. coli BL-21 RIL cells (Agilent) were then transformed and again positive clones were selected by Kanamycin resistance.

Table 1.

Primers for wcfP, Q and N PCR

Gene Sequence Restriction
sites
wcfP GCATGGAGGATCCATGAGGGATGGAAAGCCCATTGAAATACTGC BamHI
wcfP GCATGGACTCGAGTTTATGTAAAAGATTTAAATATATTCTTTCG XhoI
wcfQ GCATGGAGGATCCATGAAATTGGCTGTCATTTCTTCTATCTACAAAAATG BamHI
wcfQ GCATGGACTCGAGACGTACTGTTTTATAGATTATGTCAAGAATAGATTTAGG XhoI
wcfN GCATGGAATGGCTAGCATGAAGATATTTGCTGTAGTTGTGACCTATAATCG NheI
wcfN GCATGGACTCGAGATAGGTAGCTCCATTTTTTTTACGAAAGCAATCATAAAAGC XhoI

4.3. Expression of WcfQ, P and N

Cells containing WcfN, WcfP and WcfQ encoding plasmids were cultured in 5 mL of Luria Broth (LB) overnight at 37 °C then were used to inoculate 0.5 L of LB. Cells were grown with shaking to an O.D.600 of 0.8 and the temperature was decreased to 25 °C for 30 min. Isopropylthiogalactoside was added at a final concentration of 1 mM. Cells were allowed to incubate for an additional two hours, then were harvested by centrifugation at 4 °C for 20 min at 5000 × g, the supernatant was removed and cells were stored at −80 °C for later use.

4.4. WcfQ, WcfP and WcfN membrane fraction preparation

Expression cells were thawed in 20 mL of 50 mM Tris-HCl (pH=8.0) containing 200 mM NaCl and 20 mM imidazole then sonicated on ice for 6 min (total) with a pulse of 1 s on and 1 s off. Unbroken cells were then removed by centrifugation at 5000 × g for 15 min at 4 °C. The supernatant containing membrane and cytosolic components was then spun at 150,000 × g for 1 h at 4 °C. The pelleted membrane components were homogenized into 1 mL of 50 mM Tris-HCl (pH=8.0) 200 mM NaCl then 10-50 μL aliquots were stored at −80 °C. Total protein concentration in the membrane fractions was measured using a Bradford assay(31) with BSA as a standard. Total protein concentrations were 4.5, 12.5, and 7.0 mg/mL for WcfQ, WcfP and WcfN membrane preparations respectively. The presence of the overexpressed proteins was confirmed by SDS-PAGE and Western Blot analysis with an anti-T7-linked alkaline phosphatase antibody and anti-His/anti-rabbit-alkaline phosphatase. The presence of alkaline phosphatase was detected with NBT/BCIP (Pierce).

4.5. Isolation of WcfQ and WcfP from membrane fractions

Membrane fractions (1 mL) were homogenized in 20 mL of Tris-HCl supplemented with 1% Triton-X-100 (or 0.1% DDM) and 200 mM NaCl. The homogenized fraction was then spun at 150,000 × g for 1 h at 4° C. The pellet after centrifugation was again homogenized as described above. The supernatant from the high speed spin was mixed with 1 mL Ni-NTA Agarose for one hour at 4 °C then was poured through a column. The resin was washed with a solution of 50 mM Tris-HCl (pH=8.0), 50 mM imidazole, 200 mM NaCl 4 × 3 mL. After washing, 0.5 mL of elution buffer containing 50 mM Tris-HCl (pH=8.0), 500 mM imidazole, 200 mM NaCl was passed through the column. Another 1 mL of elution buffer was then passed through the column and collected 4 times to obtain purified protein. The presence of purified protein was confirmed by Western Blot analysis with an anti-T7 antibody as described above.

4.6. WcfQ, N and P assays

Initial glycosyltransferase screening assays was prepared with 1 μL of each membrane fraction or cell lysate (total protein membrane fraction concentrations given above) in a 100 μL solution containing 5 μM 2AA-B(7)PP-AADGal 8a, 1% Triton, 10 mM MnCl2, 25 mM Bicine (pH=8.3), 840 μM UDP-Gal, and 1 mM DTT. After 1 h each mixture was analyzed by HPLC under conditions described in general procedures. 2AA-B(8)PP-AADGal 8a (10nM) reactions were prepared under similar conditions with 60 μM UDP-Gal. Radiolabel assays were prepared in identical reaction mixtures only with 63 nM UDP-Gal (specific activity= 40 Ci/mmol label on the 6C3H) instead of unlabeled UDP-Gal and 10 nM 2AA-B(8)PP-AADGal 8a. 2AA-B(7)PPAADGal 8a (1 μM) radiolabel reactions were prepared with 12.4 μM UDP-[3H]Gal (specific activity= 0.4 Ci/mmol). Radiolabel assay fractions were collected for every minute of the HPLC analysis then each fraction was diluted in 4 mL of ECOLITE scintillation fluid and counted. Alternative sugar screening was performed with 0.05 μM 2AA-B(7)PP-AADGal 8a under similar conditions as above except MgCl2 (10 mM) was used rather than MnCl2, each sugar (UDP-Gal, UDP-Glc, UDP-GlcA, UDP-GlcNAc and UDP-GalNAc) was 0.6-0.7 mM, with 2 μL of WcfQ, WcfP or WcfN membrane fractions.

4.7. WcfQ and WcfP turnover optimization

A standard reaction was prepared containing 25 mM Bicine, 1 mM DTT, 200 mM NaCl, 10 mM MnCl2, 1% Triton-X-100, 84 μM UDP-Gal, 0.5 μM 2AA-B(8)PP-AADGal 8a. Each component was varied from these concentrations as indicated in Figure 8, WcfQ reactions contained 0.45 μg/mL total protein and WcfP reactions contained 12.5 μg/mL total protein. UDP-Gal and UDP-Glc screening was performed under identical conditions with the amount of protein and sugar concentrations as indicated in Figure 7.

4.8. Divalent metal screening

Divalent metals were screened with WcfP in reactions containing 25 mM Bicine, 1 mM DTT, 200 mM NaCl, 10 mM MnCl2, MgCl2, or CaCl2, 1% Triton-X-100, 840 μM UDP-Gal, 5 μM 2AA-B(8)PP-AADGal 8a with 62 μg/mL total protein. WcfQ was screened with 1 μM 2AAB(8)PP-AADGal 8a, 62 μM UDP-Gal and 4.5 μg/mL total protein. The influence of Mn2+ concentration was screened under identical conditions to the WcfQ reaction except with 840 μM UDP-Gal and 10, 5, 1 and 0.5 mM MnCl2.

4.9. Buffer effects on WcfQ turnover

All alternative buffers (HEPES (pH=7.4), MOPS (pH=6.3) and Tris-HCl (pH=8.0)) were 25 mM final concentration and were screened in reactions containing 620 μM UDP-Gal, 1.1 μg/mL total protein WcfQ, 1 mM DTT, 1% Triton-X-100, 200 mM NaCl, 10 mM MnCl2, 1 μM 2AA-B(8)PP-AADGal 8a.

4.10. One Pot reaction

A 200 μL solution of 25 mM Bicine (pH=8.3), 1% Triton-X-100, 1 mM MgCl2, 0.1 mM NAD+, 335 μM PLP, 5 mM glutamate, 0.16 mg/mL C. jejuni PglF130,(29) 0.6 μM B. fragilis pure WcfR,(14) 0.115 mg/mL total protein WcfS membrane fraction, 2 μM 2AA-B(8)P 7a and 150 μM UDP-Gal was assembled and incubated at room temperature. After 30 min 5 μL of the solution was analyzed by HPLC (55% isocratic conditions as above), at which point 84% of the 2AAB(8)P 7a had been converted to 2AA-B(8)PP-AADGal 8a. After 50 min of incubation 6 nmols (1 μL of a 6 mM solution) of UDP-Gal, and 5 μL of WcfQ membrane fraction was added. The solution was incubated for 5 min then 5 μL was analyzed by HPLC at which point complete conversion to disaccharide was observed.

4.11. Pure WcfQ reaction

A solution was prepared containing 0.5 μM 2AA-B(8)PP-AADGal 8a, 620 μM UDP-Gal, 25 mM Bicine, 10 mM MnCl2, 1% Triton-X-100, 1 mM DTT, and 5 μg/mL purified WcfQ then was analyzed by HPLC for product turnover.

Supplementary Material

01

Highlights.

  • - Recombinant expression of glycosyltransferases involved in Capsular Polysaccharide A biosynthesis.

  • - Function identification of two encoded glycosyltransferases with purified substrate

  • - Specificity of WcfQ and WcfP glycosyltransferases

  • - Single pot biosynthesis of a bactoprenyl diphosphate linked disaccharide with WcfQ

  • - Turnover optimization of WcfQ and WcfP

ACKNOWLEDGMENT

We thank Professor Barbara Imperiali (MIT Biology) for PglF130 expressing cells, Anahita Z. Mostafavi (UNCC Chemistry) for expression of WcfS, and Dr. Richard Jew for critical reading of this manuscript. This work was supported by a National Institutes of Health AREA grant R15GM100402 (JMT) and National Science Foundation Instrumentation grant 1337873 (UNC-Charlotte Chemistry).

ABBREVIATIONS

CPSA

Capsular Polysaccharide A

B. fragilis

Bacteroides fragilis

HPLC

High Performance Liquid Chromatography

UDP

uridine diphosphate

AADGal

N-acetyl-4-amino-6-deoxygalactopyranose

BP

bactoprenyl phosphate

BPP

bactoprenyl diphosphate

Gal

galactose

Glc

glucose

GalNAc

N-acetylgalactosamine

GlcNAc

N-acetylglucosamine

GlcA

glucouronic acid

MS

mass spectrometry

ESI

electrospray ionization

2AA

2-amideaniline

mf

membrane fraction

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Supporting Information. Primer sequences, transmembrane prediction outputs, purified protein western blot, 2AA-B(7)PP-AADGal [3H]Gal incorporation fluorescence chromatogram and scintillation counted fractions chromatogram, fluorescence HPLC chromatograms for 2AAB(8)PP-AADGal UDP-[3H]Gal reactions, and fluorescence HPLC chromatograms for 2AAB(8)PP-AADGal with UDP-Gal.

REFERENCES

  • 1.Rakoff-Nahoum S, Coyne MJ, Comstock LE. An Ecological Network of Polysaccharide Utilization among Human Intestinal Symbionts. Current Biology. 2014;24:40–49. doi: 10.1016/j.cub.2013.10.077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bertolo L, Ewing CP, Maue A, Poly F, Guerry P, Monteiro MA. The design of a capsule polysaccharide conjugate vaccine against Campylobacter jejuni serotype HS15. Carbohydr Res. 2013;366:45–49. doi: 10.1016/j.carres.2012.11.017. [DOI] [PubMed] [Google Scholar]
  • 3.Woodward R, Yi W, Li L, Zhao GH, Eguchi H, Sridhar PR, Guo HJ, Song JK, Motari E, Cai L, Kelleher P, Liu XW, Han WQ, Zhang WP, Ding Y, Li M, Wang PG. In vitro bacterial polysaccharide biosynthesis: defining the functions of Wzy and Wzz. Nature Chemical Biology. 2010;6:418–423. doi: 10.1038/nchembio.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annual Review of Biochemistry. 2006;75:39–68. doi: 10.1146/annurev.biochem.75.103004.142545. [DOI] [PubMed] [Google Scholar]
  • 5.Ochoa-Reparaz J, Mielcarz D, Ditrio L, Burroughs A, Haque-Begum S, Kasper L. Regulatory T-reg Cells Induced by PSA-producing Bacteroides Fragilis Protect Mice Against Experimental Autoimmune Encephalomyelitis. Clinical Immunology. 2009;131:S41–S42. [Google Scholar]
  • 6.Ochoa-Reparaz J, Mielcarz D, Ditrio L, Kasper L. Bacteroides fragilis regulates the induction of FoxP3(+)CD4(+)CD25(+) T-reg cell populations in peripheral lymph nodes of mice with microflora-depleted guts. Clinical Immunology. 2008;127:S53–S53. [Google Scholar]
  • 7.Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453:620–625. doi: 10.1038/nature07008. [DOI] [PubMed] [Google Scholar]
  • 8.Liu CH, Lee SM, Vanlare JM, Kasper DL, Mazmanian SK. Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc Natl Acad Sci U S A. 2008;105:3951–3956. doi: 10.1073/pnas.0709266105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122:107–118. doi: 10.1016/j.cell.2005.05.007. [DOI] [PubMed] [Google Scholar]
  • 10.Mazmanian SK, Kasper DL. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol. 2006;6:849–858. doi: 10.1038/nri1956. [DOI] [PubMed] [Google Scholar]
  • 11.Cobb BA, Kasper DL. Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens. Cell Microbiol. 2005;7:1398–1403. doi: 10.1111/j.1462-5822.2005.00591.x. [DOI] [PubMed] [Google Scholar]
  • 12.Cobb BA, Wang Q, Tzianabos AO, Kasper DL. Polysaccharide processing and presentation by the MHCII pathway. Cell. 2004;117:677–687. doi: 10.016/j.cell.2004.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Coyne MJ, Tzianabos AO, Mallory BC, Carey VJ, Kasper DL, Comstock LE. Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis. Infect Immun. 2001;69:4342–4350. doi: 10.1128/IAI.69.7.4342-4350.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mostafavi AZ, Troutman JM. Biosynthetic assembly of the Bacteroides fragilis capsular polysaccharide A precursor bactoprenyl diphosphate-linked acetamido-4-amino-6-deoxygalactopyranose. Biochemistry. 2013;52:1939–1949. doi: 10.1021/bi400126w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mostafavi AZ, Lujan DK, Erickson KM, Martinez CD, Troutman JM. Fluorescent probes for investigation of isoprenoid configuration and size discrimination by bactoprenol-utilizing enzymes. Bioorganic & Medicinal Chemistry. 2013;21:5428–5435. doi: 10.1016/j.bmc.2013.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Baumann H, Tzianabos AO, Brisson JR, Kasper DL, Jennings HJ. Structural Elucidation of 2 Capsular Polysaccharides from One Strain of Bacteroides-Fragilis Using High-Resolution Nmr-Spectroscopy. Biochemistry. 1992;31:4081–4089. doi: 10.1021/bi00131a026. [DOI] [PubMed] [Google Scholar]
  • 17.James DBA, Yother J. Genetic and Biochemical Characterizations of Enzymes Involved in Streptococcus pneumoniae Serotype 2 Capsule Synthesis Demonstrate that Cps2T (WchF) Catalyzes the Committed Step by Addition of beta 1-4 Rhamnose, the Second Sugar Residue in the Repeat Unit. Journal of Bacteriology. 2012;194:6479–6489. doi: 10.1128/JB.01135-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lujan DK, Stanziale JA, Mostafavi AZ, Sharma S, Troutman JM. Chemoenzymatic synthesis of an isoprenoid phosphate tool for the analysis of complex bacterial oligosaccharide biosynthesis. Carbohydrate Research. 2012;359:44–53. doi: 10.1016/j.carres.2012.06.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Glover KJ, Weerapana E, Imperiali B. In vitro assembly of the undecaprenylpyrophosphate-linked heptasaccharide for prokaryotic N-linked glycosylation. Proc Natl Acad Sci U S A. 2005;102:14255–14259. doi: 10.1073/pnas.0507311102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Troutman JM, Imperiali B. Campylobacter jejuni PglH is a single active site processive polymerase that utilizes product inhibition to limit sequential glycosyl transfer reactions. Biochemistry. 2009;48:2807–2816. doi: 10.1021/bi802284d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.James DB, Gupta K, Hauser JR, Yother J. Biochemical activities of Streptococcus pneumoniae serotype 2 capsular glycosyltransferases and significance of suppressor mutations affecting the initiating glycosyltransferase Cps2E. J Bacteriol. 2013;195:5469–5478. doi: 10.1128/JB.00715-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ochoa-Reparaz J, Wang Y, Mielcarz D, Haque-Begum S, Kasper D, Kasper L. A Single Polysaccharide from the Human Commensal Bacteroides fragilis Protects Against Experimental CNS Demyelinating Disease. Clinical Immunology. 2010;135:S51–S51. doi: 10.1038/mi.2010.29. [DOI] [PubMed] [Google Scholar]
  • 23.Ochoa-Reparaz J, Wang Y, Miecarz DW, Begum-Haque S, Kasper DL, Kasper LH. Oral Treatment with Purified Polysaccharide A (PSA) of Human Commensal Bacteroides fragilis Protects Against Experimental CNS Demyelinating Disease. Neurology. 2010;74:A562–A562. doi: 10.1038/mi.2010.29. [DOI] [PubMed] [Google Scholar]
  • 24.Ochoa-Reparaz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunology. 2010;3:487–495. doi: 10.1038/mi.2010.29. [DOI] [PubMed] [Google Scholar]
  • 25.Kasper LH, Shoemaker J. Multiple sclerosis immunology The healthy immune system vs the MS immune system. Neurology. 2010;74:S2–S8. doi: 10.1212/WNL.0b013e3181c97c8f. [DOI] [PubMed] [Google Scholar]
  • 26.Ochoa-Reparaz J, Mielcarz DW, Ditrio LE, Burroughs AR, Foureau DM, Haque-Begum S, Kasper LH. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol. 2009;183:6041–6050. doi: 10.4049/jimmunol.0900747. [DOI] [PubMed] [Google Scholar]
  • 27.Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001;305:567–580. doi: 10.1006/jmbi.2000.4315. [DOI] [PubMed] [Google Scholar]
  • 28.Cserzo M, Wallin E, Simon I, vonHeijne G, Elofsson A. Prediction of transmembrane alpha-helices in prokaryotic membrane proteins: the dense alignment surface method. Protein Engineering. 1997;10:673–676. doi: 10.1093/protein/10.6.673. [DOI] [PubMed] [Google Scholar]
  • 29.Olivier NB, Chen MM, Behr JR, Imperiali B. In vitro biosynthesis of UDP-N,N’-diacetylbacillosamine by enzymes of the Campylobacter jejuni general protein glycosylation system. Biochemistry. 2006;45:13659–13669. doi: 10.1021/bi061456h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Schoenhofen IC, McNally DJ, Vinogradov E, Whitfield D, Young NM, Dick S, Wakarchuk WW, Brisson JR, Logan SM. Functional characterization of dehydratase/aminotransferase pairs from Helicobacter and Campylobacter: enzymes distinguishing the pseudaminic acid and bacillosamine biosynthetic pathways. J Biol Chem. 2006;281:723–732. doi: 10.1074/jbc.M511021200. [DOI] [PubMed] [Google Scholar]
  • 31.Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  • 32.Glover KJ, Weerapana E, Chen MM, Imperiali B. Direct biochemical evidence for the utilization of UDP-bacillosamine by PglC, an essential glycosyl-1-phosphate transferase in the Campylobacter jejuni N-linked glycosylation pathway. Biochemistry. 2006;45:5343–5350. doi: 10.1021/bi0602056. [DOI] [PubMed] [Google Scholar]
  • 33.Han W, Cai L, Wu B, Li L, Xiao Z, Cheng J, Wang PG. The wciN gene encodes an alpha-1,3-galactosyltransferase involved in the biosynthesis of the capsule repeating unit of Streptococcus pneumoniae serotype 6B. Biochemistry. 51:5804–5810. doi: 10.1021/bi300640b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lombard V, Ramulu HG, Drula E, Coutinho PM, Henrissat B. The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Research. 2014;42:D490–D495. doi: 10.1093/nar/gkt1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.De Silva RA, Wang Q, Chidley T, Appulage DK, Andreana PR. Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates. J Am Chem Soc. 2009;131:9622–9623. doi: 10.1021/ja902607a. [DOI] [PubMed] [Google Scholar]
  • 36.Kreisman LSC, Friedman JH, Neaga A, Cobb BA. Structure and function relations with a T-cell-activating polysaccharide antigen using circular dichroism. Glycobiology. 2007;17:46–55. doi: 10.1093/glycob/cwl056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cobb BA, Wang O, Tzianabos AO, Kasper DL. Polysaccharide processing and presentation by the MHCII pathway. Cell. 2004;117:677–687. doi: 10.016/j.cell.2004.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Marzocca MP, Harding NE, Petroni EA, Cleary JM, Ielpi L. Location and cloning of the ketal pyruvate transferase gene of Xanthomonas campestris. J Bacteriol. 1991;173:7519–7524. doi: 10.1128/jb.173.23.7519-7524.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gardiol AE, Dazzo FB. Biosynthesis of Rhizobium-Trifolii Capsular Polysaccharide - Enzymatic Transfer of Pyruvate Substitutions into Lipid-Bound Saccharide Intermediates. Journal of Bacteriology. 1986;168:1459–1462. doi: 10.1128/jb.168.3.1459-1462.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Bossio JC, Deiannino NI, Dankert MA. Invitro Synthesis of a Lipid-Linked Acetylated and Pyruvilated Olicosaccharide in Rhizobium-Trifolii. Biochemical and Biophysical Research Communications. 1986;134:205–211. doi: 10.1016/0006-291x(86)90548-6. [DOI] [PubMed] [Google Scholar]
  • 41.Yoritsune K, Matsuzawa T, Ohashi T, Takegawa K. The fission yeast Pvg1p has galactose-specific pyruvyltransferase activity. Febs Letters. 2013;587:917–921. doi: 10.1016/j.febslet.2013.02.016. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES